Keywords: Osteoporosis, Lillly, Forteo, Merck & Co, Fosamax, Amgen, GSK, Prolia

Drug's effect on reduction of new hip fractures is greatest influence on Rxing decisions, says DR report

Article | 05 March 2010

Print This

A drug's effect on reduction of new hip fractures is the attribute that most influences, according to research findings from ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in